Intermediate metabolism in normal pregnancy and in gestational diabetes

Diabetes/Metabolism Research and Reviews

Volumn 19, Issue 4, 2003, Pages 259-270

  Di Cianni, G ^a   Miccoli, R ^a   Volpe, L ^a   Lencioni, C ^a   Del Prato, S ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Carbohydrate; Gestational diabetes mellitus; Lipid; Metabolism; Pregnancy

Indexed keywords

GLUCOSE; INSULIN;

ENERGY YIELD; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK PREGNANCY; HORMONE ACTION; HUMAN; MATERNAL MORBIDITY; METABOLIC SYNDROME X; METABOLISM; NEWBORN MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR;

DIABETES, GESTATIONAL; FEMALE; GLUCOSE; HOMEOSTASIS; HORMONES; HUMANS; INSULIN; PREGNANCY; REFERENCE VALUES;

EID: 0042093521     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.390     Document Type: Review

References (128)

1. King H. Epidemiology of glucose intolerance and gestational diabetes in women of child bearing age. Diabetes Care 1998; 21(Suppl. 2): B9-B13.
2. Engelgau MM, Herman WH, Smith PJ, German RR, Aubert RE. The epidemiology of diabetes and pregnancy in the U.S. 1988. Diabetes Care 1995; 18: 1029-1033.
3. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 1995; 44: 586-591.
4. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000; 71(Suppl. 5): 1256S-1261S.
5. Leturque A, Ferre P, Burnol AF, Kande J, Maulard P, Girard J. Glucose utilization rates and insulin sensitivity in vivo in tissues of virgin and pregnant rats. Diabetes 1986; 35: 172-177.
6. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims FA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991; 165: 1667-1672.
7. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal change in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999; 180: 903-916.
8. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990; 162: 1008-1014.
9. Buchanan TA. Metabolic changes during normal and diabetic pregnancy. In Diabetes Mellitus in Pregnancy, Reece EA, Coustan DR (eds). Churchill Livingstone: New York, 1995; 59-77.
10. Bartha J, Comino-Delgado R, Martinez-Del-Fresno P, Fernandez-Barrios M, Bethencourt I, Moreno-Corral LM. Insulin-sensitivity index and carbohydrate and lipid metabolism in gestational diabetes. J Reprod Med 2000; 45: 185-189.
11. Yamashita H, Shao J, Friedman JE. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus. Clin Obstet Gynecol 2000; 43: 87-98.
12. Kühl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 1998; 21(Suppl. 2): B19-B26.
13. Galtier-Dereure F, Boegner C, Bringer J. Obesity and pregnancy: complications and cost. Am J Clin Nutr 2000; 71(Suppl. 5): 1242S-1248S.
14. McLellan JAS, Barrow BA, Levy JC, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes. Diabetologia 1995; 38: 693-698.
15. Andersen O, Kühl C. Adipocyte insulin receptor binding and lipogenesis at term in normal pregnancy. Eur J Clin Invest 1998; 18: 575-581.
16. Hjollund H, Pedersen O, Espersen T, Klebe JG. Impaired insulin receptor binding and post-binding defect of adipocytes from normal and diabetic pregnant women. Diabetes 1986; 35: 598-603.
17. Damm P, Handber A, Kühl C, Beck-Nielsen H, Molsted-Pedersen L. Insulin receptor binding and tyrosine kinase activity in skeletal muscle from normal pregnant women and women with gestational diabetes. Obstet Gynecol 1993; 82: 251-259.
18. Shao J, Catalano PM, Yamashita H, et al. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes 2000; 49(4): 603-610.
19. Friedman JE, Ishizuka T, Shao J, Huston L, Higman TJ, Catalano P. Impaired tyrosine glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999; 48(9): 1807-1814.
20. Saad MJA, Maeda L, Brenelli SL, Carvalho CR, Palva RS, Velloso RA. Defects in insulin signal transduction in liver and muscle of pregnant rats. Diabetologia 1997; 40: 179-186.
21. Okuno S, Akazawa S, Yasuhi I, et al. Decreased expression of GLUT4 glucose transporter protein in adipose tissue during pregnancy. Horm Metab Res 1995; 27: 231-234.
22. Garvey WT, Maianu L, Zhu JH, Hancock JA, Golichowski AM. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of Glut 4 glucose transporters. Diabetes 1993; 42: 1773-1785.
23. Ishizuka T, Klepcyk P, Liu S, et al. Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. Diabetes 1999; 48: 1061-1069.
24. Goldfine ID, Maddux BA, Youngreen JF. Membrane glycoprotein PC-1 and insulin resistance. J Cell Biochem 1998; 182: 177-184.
25. Kirwan JP, Haugel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-2213.
26. Sivan E, Chen X, Homko CJ, Reece EA, Boden G. Longitudinal study of carbohydrate metabolism in healthy obese pregnant women. Diabetes Care 1997; 20: 1470-1475.
27. Catalano PM, Tyzbir ED, Wolfe RR, et al. Carbohydrate metabolism during pregnancy in control subject and women with gestational diabetes. Am J Physiol 1993; 264: E60-E67.
28. Bowes SB, Hennessy TR, Umpleby AM, et al. Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes. Diabetologia 1996; 39: 976-983.
29. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236: E667-E677.
30. Damm P, Kühl C, Hornnes P, Molsted-Pedersen L. A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Diabetes Care 1995; 18: 654-665.
31. Reaven GM, Chen Y-DI, Hollenbeck CB, Sheu WHH. Plasma insulin, C-peptide, and proinsulin concentrations in obese and non-obese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993; 76: 44-48.
32. Kautzky-Willer A, Thomaseth K, Ludvik B, et al. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes 1997; 46(4): 607-614.
33. Swinn RA, Wareham NJ, Gregory R, et al. Excessive secretion of insulin precursor characterizes and predict gestational diabetes. Diabetes 1995; 44: 911-915.
34. Hanson U, Persson B, Hartling SG, Binder C. Increased molar proinsulin-to-insulin ratio in women with previous gestational diabetes does not predict later impairment of glucose tolerance. Diabetes Care 1996; 19: 17-20.
35. Van Assche FA, Aerts L, De Prins F. A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol 1978; 85: 818-820.
36. Sorenson RL, Brelje TC, Roth C. Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology 1993; 133: 2227-2234.
37. Markoff E, Beattie GM, Hayek A, Lewis UJ. Effect of prolactin and glycosylated prolactin on (pro)insulin synthesis and insulin release from cultured rat pancreatic islets. Pancreas 1990; 5: 99-103.
38. Weinhaus AJ, Stout LE, Sorenson RL. Glucokinase, hexokinase, glucose transporter 2 and glucose metabolism in islets during pregnancy and prolactin treated islets in vitro: mechanisms for long term up-regulation of islets. Endocrinology 1996; 137: 1640-1649.
39. Brelje TC, Allaire P, Hegre OD, Sorenson RL. Effect of prolactin versus growth hormone on islets function and the importance of using homologous mammosomatotropic hormones. Endocrinology 1989; 125: 2392-2399.
40. Vasavada RC, Garcia-Ocaña A, Zawalich WS, et al. Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J Biol Chem 2000; 275: 15 399-15 406.
41. Weinhaus AJ, Bhagroo NV, Brelje TC, Sorenson RL. Role of cAMP in upregulation of insulin secretion during the adaptation of islets of Langerhans to pregnancy. Diabetes 1998; 47: 1426-1435.
42. Garcia-Ocaña A, Vasavada RC, Takane KK, Cebrian A, Lopez-Talavera JC, Stewart AF. Using beta-cell growth factors to enhance human pancreatic islet transplantation. J Clin Endocrinol Metab 2001; 86: 984-988.
43. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988; 67: 341-347.
44. Nelson T, Shulman G, Grainger D, Diamond MP. Progesterone administration induced impairment of insulin suppression of hepatic glucose production. Fertil Steril 1994; 62: 491-496.
45. Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 1993; 91: 2020-2030.
46. Kawai M, Kishi K. Adaptation of pancreatic B-cells during the last third of pregnancy: regulation of B-cell function and proliferation by lactogenic hormones in rats. Eur J Endocrinol 1999; 141: 419-425.
47. Handwerger S, Freemark M. The roles of placental growth and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab 2000; 13: 343-356.
48. Hu L, Lytras A, Bock ME, Yuen CK, Dodd JG, Cattini PA. Detection of placental growth hormone variant and chorionic somatomammotropin-L RNA expression in normal and diabetic pregnancy by reverse transcriptase-polymerase chain reaction. Mol Cell Endocrinol 1999; 157: 131-142.
49. Karabulut AK, Layfield R, Pratten MK. Growth promoting effects of human placental lactogen during early organogenesis: a link to insulin-like growth factors. J Anat 2001; 198: 651-662.
50. Brelje TC, Scharp DW, Lacy PE, et al. Effect of homologous placental lactogens prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 1993; 132(2): 879-887.
51. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
52. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombination mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
53. Butte NF, Hopkinson JM, Nicolson MA. Leptin in human reproduction: serum leptin during pregnancy and their relationship to fetal growth. J Clin Endocrinol Metab 1997; 82: 585-589.
54. Masuzaki H, Ogawa Y, Sagawa N, et al. Nonadipose tissue production of leptin: leptin as a novel placental-derived hormone in humans. Nat Med. 1997; 3: 1029-1033.
55. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations body composition and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1999; 178: 1010-1015.
56. Virkamäki A, Ueki K, Kahn CR. Protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 1999; 103: 931-943.
57. Kautzky-Willer A, Pacini G, Tura A, et al. Increased plasma leptin in gestational diabetes. Diabetologia 2001; 44: 164-171.
58. Stock SM, Bremme K. Elevation of plasma leptin during pregnancy in normal and diabetic woman. Metabolism 1998; 47: 840-843.
59. Lewandowski K, O'Callaghan CJ, Dunlop D, Medley GF, O'Hare P, Brabant G. Free leptin, bound leptin and soluble leptin receptor in normal and diabetic pregnancies. J Clin Endocrinol Metab 1999; 84: 300-306.
60. Maffei M, Volpe L, Di Cianni G, et al. Plasma leptin levels in newborns from normal and diabetic mothers. Horm Metab Res 1998; 30: 575-580.
61. Del Prato S, Castellino P, Simonson DC, DeFronzo RA. Hyperglucagonemia and insulin-mediated glucose metabolism. J Clin Invest 1987; 79: 547-556.
62. Grigorakis SI, Alevizaki M, Beis C, Anastasiou E, Alevizaki CC, Souvatzoglou A. Hormonal parameters in gestational diabetes mellitus during the third trimester: high glucagon levels. Gynecol Obstet Invest 2000; 49: 106-109.
63. Arner P. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev 2002; 18: S5-S9.
64. Butte NF, Hopkinson JM, Metha N, Moon JK, Smith EO. Adjustments in energy expenditure and substrate utilization during late pregnancy and lactation. Am J Clin Nutr 1999; 69: 299-307.
65. Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes 2002; 51(Suppl. 1): S109-S116.
66. Person B, Hanson U, Hartling SG, Binder C. Follow-up of women with previous GDM: insulin, C-peptide and proinsulin responses to oral glucose load. Diabetes 1991; 40(Suppl. 2): 136-141.
67. Metzger BE, Cho NH, Roston SM, Rodvany R. Prepregancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993; 16: 1598-1605.
68. Damm P, Kühl C, Bertelsen A, Molsted-Pedersen L. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 1992; 167: 607-616.
69. Ryan EA, O'Sullivan MJ, Skiler JS. Insulin action during pregnancy: studies with the euglycemic glucose clamp technique. Diabetes 1985; 34: 380-389.
70. Ward WK, Johnston CLW, Beard JC, Benedetti TJ, Porte D. Abnormalities of islet B-cell function, insulin action and fat distribution in women with a history of gestational diabetes: relation to obesity. J Clin Endocrinol Metab 1985; 61: 1039-1045.
71. Xiang AH, Ruth K, Trigo E, Kjos SL, Lee W, Buchanan T. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes 1999; 48: 848-854.
72. Chiu KC, Go RC, Aoki M, et al. Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning. Diabetologia 1994; 37: 104-110.
73. Damm P, Kühl C, Buschard K, et al. Prevalence and predictive value of islet cell autoantibodies and insulin antibodies in women with gestational diabetes. Diabet Med 1994; 11: 558-563.
74. Buchanan TA. Pancreatic B-Cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 989-993.
75. Pendergrass M, Fazione E, De Fronzo RA. Non insulin-dependent diabetes mellitus and gestational diabetes mellitus: same disease, another name? Diabetes Rev 1995; 3: 566-584.
76. Peters RK, Kjos SL, Xiang A, Buchanan TA. Long term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996; 347: 227-230.
77. Buchanan TA, Xiang A, Kjos SL, et al. Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes 1998; 47: 1302-1310.
78. O'Sallivan JB. Subsequent morbidity among GDM women. In Carbohydrate Metabolism in Pregnancy and the Newborn, Sutherland HW, Stowers JM (eds.) Churchill Livingstone: New York, 1984; 174-180.
79. Meyers-Seifer CH, Vohr BR. Lipid levels in former gestational diabetic mothers. Diabetes care 1996; 19: 1351-1356.
80. Verma A, Boney CM, Tucker C, Vohr BR. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 2002; 87: 3227-3235.
81. Berkowitz K, Peters R, Kjos SL, et al. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM. Diabetes 1996; 45: 1572-1579.
82. Buchanan TA, Peters R, Xiang A, et al. Prevention of type 2 diabetes after gestational diabetes. Diabetes Pregnancy Study Group of the EASD 32nd Annual Meeting 2000, Book of Abstract, 2000; 42.
83. Julius U, Fritsch H, Fritsch W, et al. Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein (a) in normolipidemic postmenopausal women. Clin Invest 1994; 72: 502-507.
84. Ginci C, Arezzini L, Terzuoli L, Pizzichini M, Marinello E. Effect of estradiol on serum triglyceride lipoprotein levels and fatty acid composition in castrated rats. Horm Metab Res 1997; 29: 504-506.
85. Knopp Rh, Zhu X, Bonnet B. Effect of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis 1994; 110(Suppl.): S83-S91.
86. Sattar N, Greer IA, Louden J, et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab 1997; 82: 2483-2491.
87. Alvarez JJ, Montelongo A, Iglesias A, Lasuncion MA, Herrera E. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res. 1996; 37: 299-308.
88. Silliman K, Tall AR, Kretchmer N, Forte TM. Unusual high-density lipoprotein subclass distribution during late pregnancy. Metabolism. 1993; 42: 1592-1599.
89. Iglesias A, Montelongo A, Herrera E, Lasuncion MA. Changes in cholesteryl ester transfer protein activity during normal gestation and postpartum. Clin Biochem 1994; 27: 63-68.
90. Silliman K, Shore V, Forte TM. Hypertriglyceridemia during late pregnancy is associated with the formation of small dense low-density lipoproteins and the presence of large buoyant high-density lipoproteins. Metabolism. 1994; 43: 1035-1041.
91. Hubel CA, Shakir Y, Gallaher MJ, McLaughlin MK, Roberts JM. Low-density lipoprotein particle size decreases during normal pregnancy in association with triglyceride increases. J Soc Gynecol Invest 1998; 5: 244-250.
92. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997; 89: 403-408.
93. Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ. Prediction of infant birth weight by GDM screening test: importance of plasma triglyceride. Diabetes Care 1992; 15: 1605-1613.
94. Metzger BE, Phelps RL, Freinkel N, Navickas IA. Effects of gestational diabetes on diurnal profiles, of plasma glucose, lipids, and individual amino acids. Diabetes Care 1980; 3: 402-409.
95. Metzger BE. Biphasic effects of maternal metabolism on fetal growth. Quintessential expression of fuel-mediated teratogenesis. Diabetes 1991; 40(Suppl. 2): 99-105.
96. Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 1991; 325: 911-916.
97. Kalhan SC. Protein metabolism in pregnancy. Am J Clin Nutr 2000; 71(Suppl. 5): 1249S-1255S.
98. de Bonoist B, Jackson AA, Hall J, Persaud C. Whole-body protein turnover in Jamaican women during normal pregnancy. Hum Nutr Clin Nutr 1985; 39: 167-179.
99. Kalan SC, Rossi KQ, Gruca LL, Super DM, Savin SM. Relation between transamination of branched chain amino acids and urea synthesis: evidence from human pregnancy. Am J Physiol 1998; 275: E423-E431.
100. Kalhan SC, Tserng K, Gilfillan G, Dierker LJ. Metabolism of urea and glucose in normal and diabetic pregnancy. Metabolism 1982; 31: 824-833.
101. Reece EA, Wiznitzer A. Cellular and biochemical mechanism of diabetic embryopathy. Isr J Obstet Gynecol 2001; 12: 148-158.
102. Drury MI, Green AT, Stronge JM. Pregnancy complicated by clinical diabetes mellitus: a study of 600 pregnancies. Am J Obstet Gynecol 1977; 49: 519-523.
103. Comess LJ, Bennet PH, Burch TA, Miller M. Congenital anomalies and diabetes in the Pima Indians of Arizona. Diabetes 1969; 18: 471-479.
104. Adashi EY, Pinto H, Tyson JE. Impact of maternal euglycaemia on fetal outcome in diabetic pregnancy. Am J Obstet Gynecol 1979; 133: 268-274.
105. Hadden DR. Diabetes in pregnancy 1985: clinical controversy. Diabetologia 1996; 29(1): 1-9.
106. Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol. 1997; 177: 1165-1171.
107. Farrel T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 2002; 19: 322-326.
108. Mills J, Baker L, Goldman A. Malformation in infants of diabetic mothers occur before the seventh week: implication for treatment. Diabetes 1979; 28: 292-298.
109. Sermer M, Naylor CD, Gare DJ. Impact of increasing carbohydrate metabolism intolerance on maternal fetal outcomes in 3637 women without gestational diabetes: the Toronto tri-hospital gestational diabetes project. Am J Obstet Gynecol 1995; 173: 146-156.
110. Verhaeghe J, Pintiaux A, van Erke E, Hennen G, Foidart JM, Igout A. Placental GH, IGF-1, IGF-binding protein, and leptin during a glucose challenge test in pregnant women: relation with maternal body weight, glucose tolerance and birth weight. J Clin Endocrinol Metab 2002; 87: 2875-2882.
111. Kajantie E, Dunkel L, Rutanen EM, et al. IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. J Clin Endocrinol Metab 2002; 87: 2171-2179.
112. Lubchenko LO. Assessment of gestational age and development at birth. Pediatr Clin North Am 1970; 17: 125-145.
113. Susa JB, Lang O. Macrosomia: lessons from animal and clinical studies. Diabetes Rev 1996; 4(11): 11-20.
114. Uvena-Celebrezze J, Catalano P. The infant of the woman with gestational diabetes mellitus. Clin Obstet Gynecol 2000; 43: 127-139.
115. Rizzo G, Arduini D, Romanini C. Accelerated cardiac growth and abnormal cardiac flow in fetuses of diabetic mothers. Obstet Gynecol 1992; 80: 369-372.
116. Veille JC, Sivakoff M, Hanson R, Fanaroff AA. Intraventricular septal thickness in fetuses of diabetic mothers. Obstet Gynecol 1992; 25: 51-54.
117. Kjos SL, Walther F. Prevalence and etiology of respiratory distress in infants of diabetic mothers: predictive value of lung maturation tests. Am J Obstet Gynecol 1990; 163(3): 898-903.
118. Cowet RM. Hypoglycemia and hyperglycemia in the newborn. In Fetal and Neonatal Physiology, Polin RA, Fox WW (eds). W. B. Saunders: Philadelphia, 1997; 406-412.
119. Cruikshank DP, Pitkin RM, Varner MV, Williams GA, Hargis GK. Calcium metabolism in diabetic mother, fetus and newborn infants. Am J Obstet Gynecol 1983; 145: 1010-1015.
120. Levine BS, Coburn JW. Magnesium, the mimic/antagonist of calcium. N Engl J Med 1984; 310: 1253-1255.
121. Marshal RE. Infants of the diabetic mothers: a neonatologist's view. Clin Diabetes 1999; 8: 49-51.
122. Shannon K, Davis JC, Kitzmiller JL, Fulcher SA, Koening HM. Erythropoiesis in infants of diabetic mothers. Pediatr Res 1986; 30: 161-165.
123. Vohr BR, McGarvey ST. Growth patterns of large for gestational age and appropriate for gestational age infants of gestational diabetic mothers and control mothers at 1 age year. Diabetes Care 1997; 20: 1066-1072.
124. Pettitt DJ, Nelson RG, Saad MF, Bennet PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993; 16: 310-314.
125. Silverman BL, Cho NH, Metzger BE. Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinsm. Diabetes Care 1995; 18: 611-617.
126. Silverman BL, Rizzo TA, Cho NH, Metzger BE. Long-term effects of the intrauterine environment. Diabetes Care 1998; 21(Suppl. 2): 142-149.
127. Pettitt DJ, Aleck KA, Baird RH. Congenital susceptibility to NIDDM: role of intrauterine environment. Diabetes 1998; 37: 622-628.
128. Silverman BL, Cho NH, Metzger BE. Impaired glucose tolerance (IGT) in adolescent offspring of diabetic mothers. Diabetes 1993; 42: 87A-92A.